Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
New heart drug shows promise in major trial for debilitating condition
Disease control CompletedThis study tested whether a new oral drug called aficamten could help adults with a specific heart condition where the heart muscle is too thick, causing symptoms like shortness of breath and limiting exercise. Over 280 participants took either the drug or a placebo pill daily fo…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new pill to ease strain on thickened hearts
Disease control CompletedThis study tested a new oral drug called aficamten (CK-3773274) in adults with symptomatic hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens and can't pump blood well. The main goal was to find safe and tolerable doses and see how the drug is processe…
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC